Quote:
Originally Posted by MDLNB
According to your SNOPES:
"$1.95 billion allocated to Pfizer was for large-scale manufacturing and nationwide distribution."
"Technically, the work conducted by Pfizer and its partner, German drugmaker BioNTech, is an expansion of OWS and was operating under an agreement to meet the goal of OWS to deliver 300 million doses of a vaccine in 2021. As part of the agreement, the U.S. government would receive 100 million doses after the successful manufacturing of the vaccine and its approval by the FDA."
|
Exactly. That was to PURCHASE PRODUCT.
It was not to fund research.